![Florent Gros](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Florent Gros
Founder at
Priothera Ltd.
Profile
Florent Gros was the founder of Amyl Therapeutics SRL, founded in 2020, serving as Chairman.
Dr. Gros is the founder of Priothera Ltd., founded in 2020, serving as Chief Executive Officer & Director.
Dr. Gros was the founder of Handl Therapeutics BV, founded in 2019, serving as Chief Executive Officer.
Dr. Gros is the founder of Priothera SAS, founded in 2020, serving as Chief Executive Officer.
Current jobs include Director at TiGenix SAU, Director at Anokion SA, Director at Inflazome Ltd., Director at Imcheck Therapeutics SAS, Managing Director at Swissvention Partners GmbH, and Partner at Bek Venture since 2020.
Former jobs include Chairman at Oculis SA, Managing Director at Novartis Venture Fund from 2007 to 2019, Director at Neovacs SA, Director at Altimmune UK Ltd., Non-Executive Director at binx health, inc., Director at Altimmune, Inc., Director at MyoPowers Medical Technologies France SAS, Director at Opsona Therapeutics Ltd., Director at Adicet Bio Israel Ltd., Director at Gensight Biologics SA, Director at Kanyos Bio, Inc., Director at Adicet Therapeutics, Inc., Director at Vivet Therapeutics SAS, Principal at Nestlé SA, Principal at Aventis Pasteur Sa, Member-Supervisory Board at Merus NV from 2014 to 2016, Independent Member-Supervisory Board at Captor Therapeutics SA, and Member-Management Board at Okairos AG.
Education includes graduation from École Supérieure de Biothechnologie Strasbourg.
Florent Gros active positions
| Companies | Position | Start |
|---|---|---|
Cellerix SA
 Cellerix SA Pharmaceuticals: GenericHealth Technology Develops and manufactures pharmaceutical products | Director/Board Member | 21/09/2011 |
Anokion SA
 Anokion SA BiotechnologyHealth Technology Operates as a biotechnology company which develops therapies for antigen-specific immune tolerance | Director/Board Member | - |
Inflazome Ltd.
 Inflazome Ltd. Pharmaceuticals: MajorHealth Technology Develops therapeutic medicines for inflammatory diseases | Director/Board Member | - |
Priothera Ltd.
 Priothera Ltd. Pharmaceuticals: MajorHealth Technology Develops hematological malignancies cells | Founder | 31/12/2019 |
Swissvention Partners GmbH | Chief Executive Officer | - |
Imcheck Therapeutics SAS
 Imcheck Therapeutics SAS Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company which develops immunotherapeutic anti-cancer strategies for research | Director/Board Member | - |
Priothera SAS
 Priothera SAS BiotechnologyHealth Technology Provides drug and clinical development services | Chief Executive Officer | 29/09/2020 |
Earlybird Venture Capital GmbH & Co. KG
 Earlybird Venture Capital GmbH & Co. KG Investment ManagersFinance Bek Ventures invests in companies located across the Europe. The firm targets companies operating in the fields of tech-enabled businesses in fintech/insurtech, enterprise software, and deep tech. It provides financing for early and growth stage capital requirements with an investment size of EUR 0.5 - 10 million. | Private Equity Investor | 31/12/2019 |
Former positions of Florent Gros
| Companies | Position | End |
|---|---|---|
Novartis Venture Funds
 Novartis Venture Funds Investment ManagersFinance NVF invests in companies located across North America and Europe. The firm focuses on biotechnology & biopharmaceutical and Life science sectors. It provides financing for early and later stage transactions with an investment size up to USD 30 million per company and also acts as lead or co-lead investor. The firm takes a seat on the board of directors. | Chief Investment Officer | 30/12/2019 |
| ░░░░░ ░░░░░░░░░░░░ ░░░ | ░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░░░ ░░░░ ░░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ |
| ░░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ |
| ░░░░ ░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | - |
Training of Florent Gros
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
72
1st degree connections
29
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 29 |
|---|---|
Nestlé SA
 Nestlé SA Food: Major DiversifiedConsumer Non-Durables Produces, supplies and markets chocolates, frozen food, ice creams, dairy products and pet food | Consumer Non-Durables |
Aventis Pasteur Sa
 Aventis Pasteur Sa Pharmaceuticals: MajorHealth Technology Researches and develops human and animal pharmaceutical products | Health Technology |
Earlybird Venture Capital GmbH & Co. KG
Earlybird Venture Capital GmbH & Co. KG Investment ManagersFinance Bek Ventures invests in companies located across the Europe. The firm targets companies operating in the fields of tech-enabled businesses in fintech/insurtech, enterprise software, and deep tech. It provides financing for early and growth stage capital requirements with an investment size of EUR 0.5 - 10 million. | Finance |
Novartis Venture Funds
Novartis Venture Funds Investment ManagersFinance NVF invests in companies located across North America and Europe. The firm focuses on biotechnology & biopharmaceutical and Life science sectors. It provides financing for early and later stage transactions with an investment size up to USD 30 million per company and also acts as lead or co-lead investor. The firm takes a seat on the board of directors. | Finance |
Neovacs SA
 Neovacs SA Pharmaceuticals: MajorHealth Technology Discovers and develops antibody therapies | Health Technology |
Altimmune UK Ltd.
 Altimmune UK Ltd. BiotechnologyHealth Technology Develops vaccines for mutating viruses | Health Technology |
Cellerix SA
Cellerix SA Pharmaceuticals: GenericHealth Technology Develops and manufactures pharmaceutical products | Health Technology |
Okairos AG
 Okairos AG Pharmaceuticals: MajorHealth Technology Discovers and develops preventive and therapeutic vaccines against human chronic infectious diseases | Health Technology |
Merus NV
 Merus NV BiotechnologyHealth Technology Discovers and develops therapeutics for cancer treatment | Health Technology |
binx health, inc.
 binx health, inc. Medical SpecialtiesHealth Technology Develops point-of-care test solutions for chlamydia and gonorrhea & related software solutions | Health Technology |
Altimmune, Inc. /Old/
 Altimmune, Inc. /Old/ Medical/Nursing ServicesHealth Services Develops vaccines and other biological products | Health Services |
MyoPowers Medical Technologies France SAS
 MyoPowers Medical Technologies France SAS Medical SpecialtiesHealth Technology Operates as a medical device company | Health Technology |
Opsona Therapeutics Ltd.
 Opsona Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Provides immunology drug for treatment of inflammatory diseases | Health Technology |
Adicet Bio Israel Ltd.
 Adicet Bio Israel Ltd. Pharmaceuticals: MajorHealth Technology Develops therapeutic molecules for cancer, viral, and autoimmune diseases | Health Technology |
Gensight Biologics SA
 Gensight Biologics SA Pharmaceuticals: MajorHealth Technology Manufactures and markets novel therapies for severe retinal neurodegenerative diseases | Health Technology |
Anokion SA
Anokion SA BiotechnologyHealth Technology Operates as a biotechnology company which develops therapies for antigen-specific immune tolerance | Health Technology |
Kanyos Bio, Inc.
 Kanyos Bio, Inc. Pharmaceuticals: MajorHealth Technology Develops therapies for type 1 diabetes | Health Technology |
Adicet Therapeutics, Inc.
 Adicet Therapeutics, Inc. BiotechnologyHealth Technology Operates as a biotechnology company | Health Technology |
École Supérieure de Biothechnologie Strasbourg
 École Supérieure de Biothechnologie Strasbourg Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Oculis SA
 Oculis SA Miscellaneous Commercial ServicesCommercial Services Operates as a clinical stage biopharmaceutical company that focuses on developing treatments for ophthalmic diseases | Commercial Services |
Inflazome Ltd.
Inflazome Ltd. Pharmaceuticals: MajorHealth Technology Develops therapeutic medicines for inflammatory diseases | Health Technology |
Imcheck Therapeutics SAS
Imcheck Therapeutics SAS Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company which develops immunotherapeutic anti-cancer strategies for research | Health Technology |
Vivet Therapeutics SAS
 Vivet Therapeutics SAS BiotechnologyHealth Technology Operates as a clinical-stage emerging biotechnology company that develops novel gene therapy treatments for rare and inherited metabolic diseases | Health Technology |
Captor Therapeutics SA
 Captor Therapeutics SA Pharmaceuticals: MajorHealth Technology Operates as a a biopharmaceutical company which develops protein degradation drugs for cancer and autoimmune diseases | Health Technology |
Priothera Ltd.
Priothera Ltd. Pharmaceuticals: MajorHealth Technology Develops hematological malignancies cells | Health Technology |
Handl Therapeutics BV
 Handl Therapeutics BV BiotechnologyHealth Technology Provides gene therapy treatment solutions | Health Technology |
Swissvention Partners GmbH | |
Amyl Therapeutics SRL
 Amyl Therapeutics SRL BiotechnologyHealth Technology Operates as a preclinical biotechnology company | Health Technology |
Priothera SAS
Priothera SAS BiotechnologyHealth Technology Provides drug and clinical development services | Health Technology |
- Stock Market
- Insiders
- Florent Gros
